Skip to main content

RAD April 2022 Conference Abstracts and Posters

224 - Baseline Patient Demographics and Comorbidities in Patients With Atopic Dermatitis From the GLOBOSTAD Registry

Piergiacomo Calzavara-Pinton, Jarmila Čelakovská, Hilde Lapeere, Mona Al-Ahmad, Chia-Yu Chu, Jiangming Wu, Marius Ardeleanu, Zafer E. Ozturk

225 - Is the severity of atopic dermatitis associated with a higher frequency of skin infections?

Jorge A. Ríos-Duarte MD, Jonathan I. Silverberg MD, PhD, MPH

228 - Feasibility of a novel, non-invasive sample collection technique to develop a molecular test guiding therapeutic selection for patients with atopic dermatitis and psoriasis

Ann P. Quick, Aaron S. Farberg, Matthew S. Goldberg, Jeff Wilkinson, Jonathan I. Silverberg

229 - Dupilumab Treatment Improved Sleep Quality in Moderate-to-Severe Atopic Dermatitis in Children Aged 6 Months to 5 Years and Their Caregivers

Amy S. Paller, Eric L. Simpson, Elaine C. Siegfried, Michael J. Cork, Andreas Wollenberg, Peter D. Arkwright, Haixin Zhang, Zhixiao Wang, Ainara R. Marco

230 - A Novel Digital Therapeutic Intervention to Improve Symptoms of Atopic Dermatitis: A Feasibility Study

Gudmundsdottir SL, Ballarini T, Ámundadóttir ML, Mészáros J, Eysteinsdottir JH, Thorleifsdottir RH, Ulfsdottir H, Hrafnkelsdottir SK, Bragadottir HB, Helgadottir H, Oddsson S, Silverberg J

231 - Risk factors and temporal associations of progression of the atopic march in children with atopic dermatitis

Junwen Deng BA, Varsha Parthasarathy BS, Zachary Bordeaux BS, Matthew Taylor BA, Melika Marani BS, Kevin Lee BS, Waleed Adawi MS, Anusha Kambala, Hannah L. Cornman, Joseph K. Canner MSH, Thomas Pritchard MPH, Ali Alajmi MD, Olusola O. Oladipo PhD, Shawn G. Kwatra MD

232 - Oral Difelikefalin Improves Itch and Quality of Life in Subjects With Itch-Dominant Atopic Dermatitis: Subgroup Analysis of a Randomized, Phase 2 Study

Mark Lebwohl, MD; Brian Kim, MD, MRT; Joana Goncalves, MD; Kristine Nograles, MD; Catherine Munera, PhD; Emma Guttman-Yassky, MD, PhD

233 - Oral Difelikefalin Improves Itch and Inflammatory Biomarkers in Atopic Dermatitis Subjects With Moderate-to-Severe Pruritus

Emma Guttman-Yassky, MD, PhD; Paola Facheris, MD; Joel Correa Da Rosa, PhD; Yeriel Estrada, BA; Eden David, BA; Ana Pavel, PhD; Swaroop Bose, MS; Joana Goncalves, MD; Kristine Nograles, MD; Brian Kim, MD, MRT; Mark Lebwohl, MD

234 - A Phase 2, Randomized, Double-Blind, Placebo-Controlled, Parallel 5-Group Study of Sphingosine-1-Phosphate Receptor Modulator BMS-986166 or Bruton’s Tyrosine Kinase Inhibitor Branebrutinib for the Treatment of Patients With Moderate-to-Severe Atopic Dermatitis

Emma Guttman-Yassky, M.D., Ph.D., Leon Carayannopoulos, M.D., Ph.D., Fareeda Hosein, M.D., Dennis M. Grasela, Pharm.D., Ph.D., Jeffrey Melin, M.D., M.P.H., Josephine Reyes, D.V.M., David Zammit, Ph.D., M.B.A., Mai Carey, M.S.

235 - Abrocitinib Reduces Skin Pain in Adolescent and Adult Patients With Moderate-to-Severe Atopic Dermatitis

Jacob P. Thyssen, Anthony Bewley, Sonja Ständer, Carla Castro, Laurent Misery, Brian Kim, Pinaki Biswas, Gary Chan, Daniela E. Myers, Melissa Watkins, Justine Alderfer, Erman Guler, Jonathan I. Silverberg

Page 5 of 7
Results 41 - 50 of 68